BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9753220)

  • 21. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor.
    Udagawa A; Shiota G; Ichiba M; Murawaki Y
    Scand J Gastroenterol; 2003 Feb; 38(2):141-6. PubMed ID: 12678329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of rebamipide on lipid peroxidation and gastric mucosal injury induced by indometacin in rats.
    Yoshikawa T; Naito Y; Nakamura S; Nishimura S; Kaneko T; Iinuma S; Takahashi S; Kondo M; Yamasaki K
    Arzneimittelforschung; 1993 Dec; 43(12):1327-30. PubMed ID: 8141822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
    Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
    Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells.
    Hahm KB; Park IS; Kim YS; Kim JH; Cho SW; Lee SI; Youn JK
    Free Radic Biol Med; 1997; 22(4):711-6. PubMed ID: 9013134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa.
    Suetsugu H; Ishihara S; Moriyama N; Kazumori H; Adachi K; Fukuda R; Watanabe M; Kinoshita Y
    J Lab Clin Med; 2000 Jul; 136(1):50-7. PubMed ID: 10882227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide.
    Choi HS; Lim JY; Chun HJ; Lee M; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS; Sul D
    Life Sci; 2013 Jul; 93(2-3):69-77. PubMed ID: 23743168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
    Masamune A; Yoshida M; Sakai Y; Shimosegawa T
    J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of rebamipide against ammonia-induced gastric mucosal lesions.
    Takaishi O; Arakawa T; Yamasaki K; Fujiwara Y; Uchida T; Tominaga K; Watanabe T; Higuchi K; Fukuda T; Kobayashi K; Kuroki T
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):78S-82S. PubMed ID: 9753231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils.
    Han BG; Kim HS; Rhee KH; Han HS; Chung MH
    Pharmacol Res; 1995 Oct; 32(4):201-7. PubMed ID: 8866835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells.
    Murata H; Yabe Y; Tsuji S; Tsujii M; Fu HY; Asahi K; Eguchi H; Kawano S; Hayashi N
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S70-5. PubMed ID: 16184424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rebamipide solution: a novel submucosal injection material to promote healing speed and healing quality of ulcers induced by endoscopic submucosal dissection.
    Fujimoto A; Uraoka T; Nishizawa T; Shimoda M; Goto O; Ochiai Y; Maehata T; Akimoto T; Mitsunaga Y; Sasaki M; Yamamoto H; Yahagi N
    Gastrointest Endosc; 2018 Apr; 87(4):1114-1120. PubMed ID: 28993136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats.
    Hagiwara T; Mukaisho K; Ling ZQ; Sakano T; Sugihara H; Hattori T
    Dig Dis Sci; 2007 Apr; 52(4):988-94. PubMed ID: 17342392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
    Fujioka T; Arakawa T; Shimoyama T; Yoshikawa T; Itoh M; Asaka M; Ishii H; Kuwayama H; Sato R; Kawai S; Takemoto T; Kobayashi K
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():146-52. PubMed ID: 12925153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
    Yoshida N; Ishikawa T; Ichiishi E; Yoshida Y; Hanashiro K; Kuchide M; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Yamamura Y; Okanoue T; Yoshikawa T
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():63-75. PubMed ID: 12925142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.
    Kobayashi M; Takeuchi M; Hashimoto S; Mizuno K; Sato Y; Narisawa R; Aoyagi Y
    Dig Dis Sci; 2012 Jan; 57(1):119-26. PubMed ID: 21842241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric cytoprotection beyond prostaglandins: cellular and molecular mechanisms of gastroprotective and ulcer healing actions of antacids.
    Tarnawski A; Ahluwalia A; Jones MK
    Curr Pharm Des; 2013; 19(1):126-32. PubMed ID: 22950493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rebamipide: a gastrointestinal protective drug with pleiotropic activities.
    Naito Y; Yoshikawa T
    Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):261-70. PubMed ID: 20528113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat.
    Kim CD; Hong KW
    J Pharmacol Exp Ther; 1995 Oct; 275(1):340-4. PubMed ID: 7562569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
    Murakami K; Okajima K; Harada N; Isobe H; Okabe H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.
    Aihara M; Azuma A; Takizawa H; Tsuchimoto D; Funakoshi Y; Shindo Y; Ohmoto Y; Imagawa K; Kikuchi M; Mukaida N; Matsushima K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):174S-180S. PubMed ID: 9753246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.